BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to SGC-7901 cell line is 130
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by qRT-PCR and Western Blotting and IF staining | NA | 0.72 | 0.5461 | 28076840 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | qRT-PCR and Western Blotting followed by SFA | NA | 0.72 | 0.5461 | 31037832 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and qRT-PCR and Western Blotting | NA | 0.72 | 0.5461 | 33731207 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and Western Blotting and qRT-PCR | NA | 0.72 | 0.5461 | 34173116 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.72 | 0.5461 | 31261030 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | Cisplatin | SFA followed by qRT-PCR and Western Blotting | NA | 0.72 | 0.5461 | 33579380 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting and qRT-PCR | NA | 0.72 | 0.5461 | 28415621 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | FACs for CSC marker followed by Western Blotting | NA | 0.72 | 0.5461 | 27279633 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and Western Blotting | NA | 0.72 | 0.5461 | 34350176 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and Western Blotting | NA | 0.72 | 0.5461 | 34646768 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and Western Blotting | NA | 0.72 | 0.5461 | 34657624 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting | NA | 0.72 | 0.5461 | 27644439 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting | NA | 0.72 | 0.5461 | 30007956 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting | NA | 0.72 | 0.5461 | 34802261 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting | NA | 0.72 | 0.5461 | 30624124 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | Western Blotting followed by SFA | NA | 0.72 | 0.5461 | 31517391 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | qRT-PCR followed by SFA | NA | 0.72 | 0.5461 | 29662192 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | CFA and IHC staining followed by FACs and Western Blotting | NA | 0.64 | 1 | 26276718 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and FACs followed by qRT-PCR and Western Blotting | NA | 0.64 | 1 | 33608016 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by FACs and qRT-PCR and Western Blotting | NA | 0.64 | 1 | 33731207 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.64 | 1 | 30843262 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.64 | 1 | 31261030 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | Four-dimensional (4D) culture model by a magnetic responsive alginate-based hydrogel to rotating magnets followed by RT-PCR and IF staining | NA | 0.64 | 1 | 33836517 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and Western Blotting followed by FACs | NA | 0.64 | 1 | 34657624 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by FACs and Western Blotting | NA | 0.64 | 1 | 31517391 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting and FACs | NA | 0.64 | 1 | 30624124 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | FACs followed by IF staining and SFA | NA | 0.64 | 1 | 29662192 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and Western Blotting | NA | 0.64 | 1 | 34090492 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and Western Blotting | NA | 0.64 | 1 | 34350176 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting | NA | 0.64 | 1 | 27644439 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting | NA | 0.64 | 1 | 29422082 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by qRT-PCR | NA | 0.64 | 1 | 32142918 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by RT-PCR | NA | 0.64 | 1 | 32051395 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and FACs | NA | 0.64 | 1 | 34646768 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by FACs | NA | 0.64 | 1 | 34802261 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | FACs | NA | 0.64 | 1 | 32926650 |
| MSI1 | 7330 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | CFA and IHC staining followed by FACs and Western Blotting | NA | 0.64 | 0.0201 | 26276718 |
| ANTXR2 | 21732 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | FACs and qRT-PCR followed by Western Blotting and SFA | NA | 0.6 | 0.0042 | 29662192 |
| ALDH1A1 | 402 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and qRT-PCR followed by Western Blotting | NA | 0.48 | 0.684 | 34427968 |
| ALDH1A1 | 402 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and Western Blotting | NA | 0.48 | 0.684 | 34090492 |
| ALDH1A1 | 402 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and Western Blotting | NA | 0.48 | 0.684 | 34646768 |
| ALDH1A1 | 402 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.684 | 30624124 |
| ALDH1A1 | 402 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | ALDEFLUOR assay followed by SFA | NA | 0.48 | 0.684 | 27279633 |
| ALDH1A1 | 402 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by ALDEFLUOR assay | NA | 0.48 | 0.684 | 34173116 |
| ALDH1A1 | 402 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by ALDEFLUOR assay | NA | 0.48 | 0.684 | 34802261 |
| ALDH3A1 | 405 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | FACs for CSC marker followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.0074 | 27279633 |
| BMI1 | 1066 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting and qRT-PCR | NA | 0.48 | 0.1135 | 28415621 |
| BMI1 | 1066 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | FACs for CSC marker followed by Western Blotting | NA | 0.48 | 0.1135 | 27279633 |
| BMI1 | 1066 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.1135 | 27644439 |
| CD274 | 17635 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | Cisplatin | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.0032 | 33579380 |
| GLI1 | 4317 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | CFA followed by qPCR and Western Blotting | NA | 0.48 | 0.0308 | 26276718 |
| GLI1 | 4317 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and Western Blotting | NA | 0.48 | 0.0308 | 34350176 |
| GLI1 | 4317 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.0308 | 30624124 |
| MALAT1 | 29665 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | qRT-PCR and Western Blotting followed by SFA | NA | 0.48 | 0.0074 | 31037832 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and qRT-PCR and Western Blotting | NA | 0.48 | 0.6448 | 33731207 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and qRT-PCR followed by Western Blotting | NA | 0.48 | 0.6448 | 34427968 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and Western Blotting and qRT-PCR | NA | 0.48 | 0.6448 | 34173116 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.6448 | 28076840 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.6448 | 30843262 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.6448 | 31261030 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | Cisplatin | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.6448 | 33579380 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting and qRT-PCR | NA | 0.48 | 0.6448 | 28415621 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | FACs for CSC marker followed by Western Blotting | NA | 0.48 | 0.6448 | 27279633 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and Western Blotting | NA | 0.48 | 0.6448 | 34090492 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and Western Blotting | NA | 0.48 | 0.6448 | 34350176 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and Western Blotting | NA | 0.48 | 0.6448 | 34646768 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and Western Blotting | NA | 0.48 | 0.6448 | 34657624 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and Western Blotting | NA | 0.48 | 0.6448 | 34845198 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.6448 | 27644439 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.6448 | 29422082 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.6448 | 30007956 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.6448 | 34802261 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.6448 | 30624124 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | Western Blotting followed by SFA | NA | 0.48 | 0.6448 | 31517391 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | qRT-PCR followed by SFA | NA | 0.48 | 0.6448 | 29662192 |
| PRKCD | 9399 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.0032 | 31261030 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.7582 | 30843262 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.7582 | 31261030 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting and qRT-PCR | NA | 0.48 | 0.7582 | 28415621 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | Four-dimensional (4D) culture model by a magnetic responsive alginate-based hydrogel to rotating magnets followed by RT-PCR and IF staining | NA | 0.48 | 0.7582 | 33836517 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by FACs and Western Blotting | NA | 0.48 | 0.7582 | 34350176 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.7582 | 27644439 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.7582 | 30624124 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and FACs | NA | 0.48 | 0.7582 | 34646768 |
| PRR11 | 25619 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.0032 | 30007956 |
| SHH | 10848 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | CFA followed by qPCR and Western Blotting | NA | 0.48 | 0.0201 | 26276718 |
| SHH | 10848 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and Western Blotting | NA | 0.48 | 0.0201 | 34350176 |
| SHH | 10848 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.0201 | 30624124 |
| SNAI1 | 11128 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and qRT-PCR followed by Western Blotting | NA | 0.48 | 0.0212 | 33608016 |
| SNAI2 | 11094 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and qRT-PCR followed by Western Blotting | NA | 0.48 | 0.0159 | 33608016 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | qRT-PCR and Western Blotting followed by SFA | NA | 0.48 | 0.5695 | 31037832 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and qRT-PCR and Western Blotting | NA | 0.48 | 0.5695 | 33731207 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and qRT-PCR followed by Western Blotting | NA | 0.48 | 0.5695 | 34427968 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and Western Blotting and qRT-PCR | NA | 0.48 | 0.5695 | 34173116 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.5695 | 30843262 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | Cisplatin | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.5695 | 33579380 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting and qRT-PCR | NA | 0.48 | 0.5695 | 28415621 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and Western Blotting | NA | 0.48 | 0.5695 | 34350176 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and Western Blotting | NA | 0.48 | 0.5695 | 34657624 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.5695 | 27644439 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.5695 | 30007956 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.5695 | 34802261 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | Western Blotting followed by SFA | NA | 0.48 | 0.5695 | 31517391 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.5695 | 32142918 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | qRT-PCR followed by SFA | NA | 0.48 | 0.5695 | 29662192 |
| TWIST1 | 12428 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and qRT-PCR followed by Western Blotting | NA | 0.48 | 0.0191 | 33608016 |
| USP22 | 12621 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting and qRT-PCR | NA | 0.48 | 0.0032 | 28415621 |
| ABCB1 | 40 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | Four-dimensional (4D) culture model by a magnetic responsive alginate-based hydrogel to rotating magnets followed by RT-PCR and IF staining | NA | 0.44 | 0.0604 | 33836517 |
| NANOGP8 | 23106 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by qPCR and IF staining | NA | 0.44 | 0.0011 | 29689047 |
| CBX7 | 1557 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0011 | 29422082 |
| CD24 | 1645 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.456 | 29422082 |
| CD24 | 1645 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by FACs | NA | 0.28 | 0.456 | 31261030 |
| CD24 | 1645 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by FACs | NA | 0.28 | 0.456 | 34802261 |
| EPCAM | 11529 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and Western Blotting | NA | 0.28 | 0.211 | 34350176 |
| EPCAM | 11529 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and FACs | NA | 0.28 | 0.211 | 33608016 |
| GLI2 | 4318 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0106 | 30624124 |
| MYC | 7553 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.1304 | 30007956 |
| MYC | 7553 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | Western Blotting followed by SFA | NA | 0.28 | 0.1304 | 31517391 |
| MYC | 7553 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.1304 | 32142918 |
| NOTCH1 | 7881 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and Western Blotting | NA | 0.28 | 0.0477 | 34845198 |
| OTUB2 | 20351 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and Western Blotting | NA | 0.28 | 0.0021 | 34646768 |
| SLC38A2 | 13448 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and Western Blotting | NA | 0.28 | 0.0011 | 34173116 |
| SMO | 11119 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and Western Blotting | NA | 0.28 | 0.0212 | 34350176 |
| SMO | 11119 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0212 | 30624124 |
| SOX9 | 11204 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA and Western Blotting | NA | 0.28 | 0.0244 | 34845198 |
| LGR5 | 4504 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by IF staining | NA | 0.24 | 0.0753 | 29689047 |
| KLF4 | 6348 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0891 | 32142918 |
| MIR200B | 31579 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | qRT-PCR | NA | 0.2 | 0.0032 | 32926650 |
| MIR21 | 31586 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0085 | 27644439 |
| CACNA2D1 | 1399 | LTM | Gastric Cancer | Adenocarcinoma | SGC-7901 | NA | FACs followed by SFA | NA | 0.12 | 0.0064 | 31213895 |